Free tool
Heavily traded stocks
We cover 159 companies whose typical session turns over more than $10.00M. The median market value in the group is $1.32B. Across the group, the median move over the past trading day is −0.38%. 64% of the 158 with a 200-day average trade above it. Price change over the past year runs from −30.0% to +177.7% across the middle 80 percent of the group, with a median of +14.6%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
159 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% | Nov 5, 2026 |
| FLRY3.SA | Fleury S.A. | $1.97B | Small cap | +37.82% | Nov 5, 2026 |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% | Nov 4, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% | Nov 5, 2026 |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% | Nov 5, 2026 |
| SNDA | Sonida Senior Living, Inc. | $1.91B | Small cap | +51.53% | Nov 9, 2026 |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% | Nov 5, 2026 |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% | Nov 9, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% | Nov 4, 2026 |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% | Nov 9, 2026 |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% | Nov 3, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% | Nov 5, 2026 |
| 4540.T | Tsumura & Co. | $1.79B | Small cap | +10.98% | Nov 9, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% | Nov 12, 2026 |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% | Nov 2, 2026 |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% | Nov 6, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% | Nov 2, 2026 |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% | Nov 5, 2026 |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% | Nov 6, 2026 |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% | Nov 5, 2026 |
| 7716.T | Nakanishi Inc. | $1.65B | Small cap | +52.27% | Nov 5, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% | Nov 10, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| 8129.T | Toho Holdings Co., Ltd. | $1.62B | Small cap | −24.33% | Nov 12, 2026 |
| AGL | agilon health, inc. | $1.61B | Small cap | +194.58% | Nov 3, 2026 |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% | Nov 5, 2026 |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% | Nov 16, 2026 |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% | Nov 5, 2026 |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% | Oct 21, 2026 |
| 8086.T | Nipro Corporation | $1.57B | Small cap | +4.28% | Nov 10, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% | Oct 22, 2026 |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% | Nov 4, 2026 |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% | Nov 12, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% | Nov 16, 2026 |
| CNMD | CONMED Corporation | $1.53B | Small cap | −6.91% | Nov 4, 2026 |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% | Nov 4, 2026 |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% | Oct 29, 2026 |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.52B | Small cap | +19.48% | Nov 13, 2026 |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% | Nov 5, 2026 |
| 6849.T | Nihon Kohden Corporation | $1.50B | Small cap | −7.26% | Nov 10, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% | Nov 5, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% | Nov 20, 2026 |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% | Nov 5, 2026 |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% | Nov 4, 2026 |
| ENOV | Enovis Corporation | $1.46B | Small cap | −18.60% | Nov 4, 2026 |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% | Nov 4, 2026 |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% | Oct 29, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% | Nov 12, 2026 |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% | Nov 11, 2026 |
| 4483.T | JMDC Inc. | $1.42B | Small cap | −17.21% | Nov 5, 2026 |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% | Nov 12, 2026 |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% | Nov 12, 2026 |
| 9627.T | Ain Holdings Inc. | $1.38B | Small cap | +2.85% | Sep 14, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| 3360.T | Ship Healthcare Holdings, Inc. | $1.35B | Small cap | +8.25% | Nov 10, 2026 |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% | Nov 5, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| AORT | Artivion, Inc. | $1.33B | Small cap | −37.81% | Nov 5, 2026 |
| AMN | AMN Healthcare Services, Inc. | $1.33B | Small cap | +70.26% | Nov 5, 2026 |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% | Nov 5, 2026 |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% | Nov 4, 2026 |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% | Oct 29, 2026 |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% | Nov 12, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% | Nov 11, 2026 |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% | Nov 5, 2026 |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% | Nov 5, 2026 |
| 2175.T | SMS Co., Ltd. | $1.24B | Small cap | +54.71% | Oct 29, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% | Nov 5, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% | Nov 3, 2026 |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.22B | Small cap | +34.65% | Nov 9, 2026 |
| 6523.T | PHC Holdings Corporation | $1.21B | Small cap | +58.42% | Nov 11, 2026 |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% | Nov 4, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.18B | Small cap | −12.86% | Nov 13, 2026 |
| USPH | U.S. Physical Therapy, Inc. | $1.17B | Small cap | −5.67% | Nov 4, 2026 |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% | Nov 5, 2026 |
| TDOC | Teladoc Health, Inc. | $1.15B | Small cap | −18.22% | Oct 28, 2026 |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% | Nov 11, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% | Nov 13, 2026 |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% | Nov 3, 2026 |
| 7476.T | AS ONE Corporation | $1.11B | Small cap | +2.31% | Oct 30, 2026 |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% | Nov 12, 2026 |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $1.06B | Small cap | −1.28% | Oct 30, 2026 |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −2.60% | Nov 2, 2026 |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% | Nov 2, 2026 |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% | Nov 2, 2026 |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% | Nov 9, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% | Nov 5, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% | Nov 4, 2026 |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% | Nov 12, 2026 |
| 7730.T | Mani, Inc. | $994.58M | Small cap | +29.48% | Oct 15, 2026 |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% | Oct 29, 2026 |
| 4521.T | Kaken Pharmaceutical Co., Ltd. | $949.35M | Small cap | +10.07% | Nov 10, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% | Nov 9, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% | Oct 22, 2026 |
| 3046.T | JINS HOLDINGS Inc. | $911.23M | Small cap | −22.48% | Oct 9, 2026 |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% | Nov 11, 2026 |
| 7780.T | Menicon Co., Ltd. | $873.71M | Small cap | +54.36% | Nov 13, 2026 |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% | Oct 27, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% | Nov 3, 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% | Nov 10, 2026 |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% | Nov 5, 2026 |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% | Nov 6, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| OXB.L | Oxford Biomedica plc | $847.14M | Small cap | −9.81% | Sep 23, 2026 |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% | Nov 12, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% | Nov 5, 2026 |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% | Nov 4, 2026 |
| 7575.T | Japan Lifeline Co., Ltd. | $694.70M | Small cap | +12.02% | Oct 29, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% | Nov 6, 2026 |
| 4565.T | Nxera Pharma Co., Ltd. | $648.21M | Small cap | +22.68% | Oct 30, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% | Nov 3, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% | Nov 5, 2026 |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% | Nov 5, 2026 |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% | Nov 10, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% | Nov 3, 2026 |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% | Nov 5, 2026 |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% | Nov 16, 2026 |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% | Nov 5, 2026 |
| 4480.T | Medley, Inc. | $512.99M | Small cap | +9.22% | Nov 12, 2026 |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% | Sep 14, 2026 |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% | Nov 10, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% | Nov 5, 2026 |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $422.50M | Small cap | −19.86% | Nov 9, 2026 |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $406.58M | Small cap | −9.63% | Oct 29, 2026 |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% | Aug 27, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% | Aug 31, 2026 |
| 7779.T | CYBERDYNE Inc. | $307.38M | Small cap | +12.08% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.